Liquid facelift · Biostimulator

Novuma:
Understanding a Biostimulator Before Treatment

Novuma is an injectable presented as a biostimulator, a product intended to encourage the skin’s own collagen production.

Its exact composition, manufacturer and registration status in Türkiye should be confirmed from official product documentation and traceability records before any treatment. Whether it is appropriate for you, and for which area, is assessed in person alongside other options.

Category
Presented as a biostimulator
Composition
To be confirmed from product documents
Onset
Typically gradual
First step
In-person assessment

What is Novuma?

Novuma is an injectable presented as a biostimulator, meaning it aims to stimulate collagen rather than simply add volume. Its composition and manufacturer should be verified from official documentation before treatment.

Biostimulators are products that set off a controlled response in the tissue in order to encourage collagen production over time, rather than relying on immediate volume. The category includes different active substances, such as calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA) and PDLLA. Novuma is one of the products referred to in this group. Accurate information about its exact composition, manufacturer and registration in Türkiye should come from the manufacturer’s own documents.

Rather than repeat unverified details, this page explains how a product like this is assessed. How a biostimulator behaves, where it can be used and which risks are most relevant depend largely on its active substance. The physician therefore decides whether it is suitable for you only after its composition has been confirmed and your face has been examined in person, and may recommend a different approach altogether.

Why does the composition matter, and how is it checked?

The active substance determines reversibility, session planning, suitable areas and the risk profile. Composition is checked against the instructions for use, the packaging and the product’s traceability record in Türkiye.

CaHA products, for example, may give some early support, while PLLA-based products act more gradually and usually need several sessions. In products that also contain hyaluronic acid, only the HA component can be dissolved with an enzyme. These differences mean that products grouped under the same “biostimulator” label are not interchangeable, and giving session numbers or durations for Novuma before its subclass is confirmed would not be accurate.

In Türkiye, the traceability of medical devices is monitored through the national Product Tracking System (ÜTS). Before treatment you are entitled to see the box, batch number and expiry date and to ask about the label details. These checks are a basic step for authenticity and safety, particularly if you are visiting from abroad and are unfamiliar with local products. A product whose content or source cannot be confirmed should not be used.

What might Novuma address, and what can it not?

Biostimulators generally aim to provide gradual support for volume loss and declining skin quality. Sharp contour change or correction of advanced sagging should not be expected.

Products in the biostimulator category may be considered for widespread volume loss, reduced skin firmness and changes in skin quality. The effect usually develops over weeks and months, and how much change occurs depends on your collagen response, age and lifestyle. Which areas Novuma is intended for should be determined from its instructions for use and its registration scope in Türkiye, and your physician will explain this at consultation.

If a visible change on the day is the priority, other product classes may be more appropriate. Marked excess skin and advanced sagging may lie beyond what injections can address; biostimulators are not equivalent to a surgical facelift. In thin areas such as the lips and around the eyes, the risk of nodules may be relevant depending on the active substance, so use there is considered carefully if at all.

Who may not be suitable?

Biostimulators are not used during pregnancy or breastfeeding, with active infection in the area or with a known allergy to their components. A tendency to keloid scarring and immune conditions need careful assessment.

Treatment is not carried out, or is postponed, during pregnancy and breastfeeding, with active infection or cold sores in the area, or with a known allergy to any component. Because biostimulators work through a tissue response, a tendency to keloid scarring, active autoimmune disease and treatments that affect the immune system are assessed with particular care. Bleeding disorders and blood thinners are also discussed at consultation.

If the product’s composition or registration cannot be confirmed, treatment is not advised. Areas previously treated with unknown fillers are assessed separately. Biostimulators may also not be the right choice for someone who wants a quick, obvious change or expects a result equivalent to surgery. All of these points are discussed alongside your medical history at an in-person consultation, and a decision may be deferred until further information is available.

What does treatment involve, and what are the risks?

Treatment starts with assessment, product verification and planning; biostimulators usually involve several sessions and reviews. Swelling, bruising, nodules and, rarely, vascular occlusion are possible.

On the day, the skin is disinfected and the product is prepared according to its instructions and placed with a needle or cannula depending on the area. Avoiding strenuous exercise, saunas, alcohol and pressure on the face for 24 to 48 hours is usually advised. With some biostimulators, massage afterwards may be recommended, depending on the active substance. Follow-up visits allow the gradual effect and any irregularities to be monitored.

Common effects include swelling, redness, tenderness and bruising. With biostimulators, small nodules under the skin may be noticed weeks or even months later, and granulomas can occur rarely. Vascular occlusion is rare but serious and requires urgent assessment. Because the detail of these risks depends on the active substance, they are discussed in person once the product’s composition has been confirmed and before any treatment goes ahead.

Frequently asked questions

Is Novuma a filler?

It is presented as a biostimulator, so its main aim is to stimulate collagen rather than add immediate volume. Its exact composition, and whether it has any filler-like effect, should be confirmed from the manufacturer’s documents.

How long does Novuma last?

Duration depends on the active substance, the area treated and your metabolism. Without verified product information it would not be accurate to quote a figure; your likely duration is discussed at consultation.

How can I tell whether the product used is genuine?

You are entitled to see the box, batch number and expiry date before treatment and to ask about the label. In Türkiye, product traceability is recorded through the ÜTS system.

Might a different product be recommended instead?

Yes. Depending on your needs, the physician may suggest another biostimulator, an HA filler, toxin or no injectable at all. Product choice is always based on the in-person assessment.

Can Novuma be dissolved?

Whether Novuma can be dissolved depends on its active substance, which should be confirmed from the product’s official documents. The enzyme hyaluronidase dissolves only hyaluronic acid; it does not dissolve biostimulator components such as CaHA, PLLA or PDLLA. So even if Novuma contains hyaluronic acid, it should not be assumed to be fully reversible, and treatment is planned with that in mind.

Which symptoms after Novuma mean I should see a doctor straight away?

After Novuma, contact the treating physician straight away if you notice skin blanching, a purplish net-like discolouration or severe, worsening pain, as these can signal a blocked blood vessel. Any change in vision is an emergency: go to the nearest emergency department at once. Spreading redness and warmth with a fever also need prompt review, while mild swelling and bruising are common early on.

What should I ask my doctor if Novuma is recommended?

If Novuma is recommended, ask your physician about its active substance, manufacturer and registration status in Türkiye. It is also worth asking how many sessions are planned, when the effect should appear, whether the product can be dissolved and what would be done if a nodule or other problem occurred. Asking which alternatives to Novuma could be considered also helps clarify your decision.

Can I have Novuma if I’ve had another biostimulator before?

Yes, Novuma can be considered after another biostimulator, but the name, active substance, date and area of the earlier product need to be known. As the collagen response from the previous product may still be developing, it may be sensible to let it settle before adding something new. If you had nodules or prolonged swelling after the earlier treatment, mention this at consultation.

This content is for general information and does not replace a personal medical assessment.

Istanbul · Nişantaşı

What is right for you becomes clear at consultation.

Let’s look at your expectations, health history and facial anatomy together.

Terrace Fulya Center, Hakkı Yeten Cd. No:11, TeşvikiyeMonday – Saturday 11:00–19:00Directions